HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

O,O'- bis- (3'- iodopropyl)- 1,4- dihydroxyanthraquinone

an immunomodulator; structure in first source

Also Known As:

DIPDHAQ

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Almeida, Mauro V: 1 article (10/2012)
2.	Alves, Caio C S: 1 article (10/2012)
3.	Alves, Chrystian J: 1 article (10/2012)
4.	Castro, Sandra B R: 1 article (10/2012)
5.	Costa, Cristiane F: 1 article (10/2012)
6.	Dias, Alyria T: 1 article (10/2012)
7.	Ferreira, Ana Paula: 1 article (10/2012)
8.	Rodrigues, Michele F: 1 article (10/2012)
9.	Teixeira, Henrique C: 1 article (10/2012)

Related Diseases

1.	Multiple Sclerosis 10/01/2012 - "Therefore, the findings suggest a major role for DIPDHAQ in multiple sclerosis, disease characterized as an autoimmune inflammatory disorder against myelin proteins of the brain and spinal cord. "
2.	Inflammation (Inflammations) 10/01/2012 - "The attenuation of inflammation and consequently improvement of clinical signs, involving a decrease of pro-inflammatory cytokines and the low cytotoxicity of DIPDHAQ, suggest that this compound could be used as an alternative treatment for autoimmune diseases in the central nervous system."
3.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/01/2012 - "Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihydroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis."
4.	Autoimmune Diseases (Autoimmune Disease) 10/01/2012 - "The attenuation of inflammation and consequently improvement of clinical signs, involving a decrease of pro-inflammatory cytokines and the low cytotoxicity of DIPDHAQ, suggest that this compound could be used as an alternative treatment for autoimmune diseases in the central nervous system."

Related Drugs and Biologics

1.	Cytokines
2.	Myelin Proteins
3.	Anthraquinones